Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study
Weigert, G; Michels, S; Sacu, S; Varga, A; Prager, F; Geitzenauer, W; Schmidt-Erfurth, U (2008). Intravitreal bevacizumab (Avastin) therapy versus photodynamic therapy plus intravitreal triamcinolone for neovascular age-related macular degeneration: 6-month results of a prospective, randomised, controlled clinical study. British Journal of Ophthalmology, 92(3):356-360.
Additional indexing
| Item Type: | Journal Article, refereed, original work |
|---|---|
| Communities & Collections: | 04 Faculty of Medicine > University Hospital Zurich > Ophthalmology Clinic |
| Dewey Decimal Classification: | 610 Medicine & health |
| Scopus Subject Areas: | Health Sciences > Ophthalmology
Life Sciences > Sensory Systems Life Sciences > Cellular and Molecular Neuroscience |
| Language: | English |
| Date: | March 2008 |
| Deposited On: | 21 Nov 2008 13:21 |
| Last Modified: | 03 Oct 2024 03:30 |
| Publisher: | BMJ Publishing Group |
| ISSN: | 0007-1161 |
| OA Status: | Hybrid |
| Publisher DOI: | https://doi.org/10.1136/bjo.2007.125823 |
| PubMed ID: | 18303156 |
Permanent URL
https://doi.org/10.5167/uzh-5069
Download
Preview
Links
Statistics
Citations
Dimensions.ai Metrics
Weigert, G